Psychosis in dementia or dementia in psychosis? A clinical approach to a common puzzle

Overlapping and interacting problems of late-life psychosis, depression and cognitive decline – including dementia – make geriatric psychiatry a demanding and rewarding area in which to work, Vimal Aga (Portland, Oregon, USA) told APA’s 2021 Annual Meeting. With a rapidly growing elderly population, it is also one with a pressing need for expertise.

A large national US study in Medicare patients has just shown that 27.9% of 66 year-olds with a diagnosis of schizophrenia also have a diagnosis of dementia.1 This compares with a 1.3% rate of dementia among people of the same age without serious mental illness. By 80 years of age, the prevalence of dementia is 70.2% in people with schizophrenia and 11.3% in others.

At 66 years of age, the prevalence of dementia among people with schizophrenia is the same as that of 88 year olds without serious mental illness.

High rates of dementia among older schizophrenia patients will impact treatment and service use1

 

Cognitive disorders can mimic psychosis

While some cases are vascular in origin, or Alzheimer’s disease, many elderly patients with schizophrenia have undifferentiated dementias, Dr Aga said.

The connection is also evident the other way round. Neurocognitive disorders are commonly associated with late-onset psychosis, and International Psychogeriatric Association criteria for their diagnosis in such disorders have recently been updated.2 A third or more of patients with Alzheimer’s disease have psychotic symptoms at any given time.3

Even in their prodromal phase, neurocognitive disorders can mimic a primary psychiatric disorder, making differential diagnosis a major challenge, noted Dr Aga. 

There is a complex interface between aging, psychosis, and cognitive decline

 

Insights from experience

Dr Aga also made a number of other clinical observations about the diagnosis and management of geriatric mental health disorders:

  • Late onset schizophrenia seems to be less related to a family history, suggesting lower genetic loading
  • Agitated depression with psychotic features can be difficult to differentiate from late-onset schizophrenia. Both can present with cognitive impairment, psychotic features and depression. It is helpful to distinguish whether depression or psychosis came first. The presence of first-rank symptoms such as delusions of control suggests schizophrenia.
  • Biomarkers can be helpful in the differential diagnosis of depression, psychosis and dementia. While obtaining CSF markers is invasive, and serum markers are not yet ready for routine use, MRI is accessible and informative. MRI should involve specific sequences and include volumetric analysis.
  • In treating depression with psychosis, it is appropriate to start with antidepressants, with ECT a possibility – even in the presence of cognitive symptoms -- when there is high risk of suicide. Combining antidepressants with an antipsychotic can be helpful, with the latter used with caution in patients who are frail, and titrated from a low dose. Brain atrophy may make Transcranial Magnetic Stimulation less effective in treating depression in older adults.
  • With agitation in AD dementia, the first question is whether it is psychotic in origin. If so, an antipsychotic is the first option. If not, the agitation  may respond well to an SSRI.4,5
  • Lewy Body dementia responds well to cognitive enhancers.

 

For the latest updates on sea.progress.im, subscribe to our Telegram Channel https://bit.ly/telePiM

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. Stroup TS et al. Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia. JAMA Psychiatry 2021 Mar 10;e210042. doi: 10.1001/jamapsychiatry.2021.0042

2. Cummings J et al. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition. Am J Geriatr Psychiatry 2020;28: 1256-1269

3. Sweet RA et al. Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Molecular Psychiatry 2003; 8: 383–92

4. Aga VM. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram. Am J Geriatr Psychiatry 2019;27:1099-107

5. Ehrhardt S et al. Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement 2019;15:1427-36

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country